新冠肺炎后格林-巴利综合征复发。

IF 1.2 4区医学 Q4 CLINICAL NEUROLOGY Neurosciences Pub Date : 2023-10-01 DOI:10.17712/nsj.2023.4.20230012

Svetlana D Miletic Drakulic, Snezana R Lazarevic, Ivana P Miloradovic, Vladimir S Jankovic

{"title":"新冠肺炎后格林-巴利综合征复发。","authors":"Svetlana D Miletic Drakulic, Snezana R Lazarevic, Ivana P Miloradovic, Vladimir S Jankovic","doi":"10.17712/nsj.2023.4.20230012","DOIUrl":null,"url":null,"abstract":"Coronavirus disease 19 (COVID-19) is known to manifest itself predominantly with respiratory symptoms. However, previous experiences with this disease and many scientific studies have drawn attention to its neurological manifestations. The link between COVID-19 and many neurological diseases, including Guillain Barré syndrome (GBS), has been pointed out. Although GBS is considered a monophasic disease, its relapses occur in 2-6% of cases. We present the case of a female patient with recurrent GBS caused by COVID-19. Given that 2-6% of patients experience a relapse of GBS, and that the COVID-19 pandemic is recognized as a possible trigger of the relapse, we emphasize the importance of intensive neurological monitoring for patients diagnosed with COVID-19 who have a history of GBS.","PeriodicalId":19284,"journal":{"name":"Neurosciences","volume":"28 4","pages":"273-276"},"PeriodicalIF":1.2000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10827027/pdf/","citationCount":"0","resultStr":"{\"title\":\"Reccurent guillain barré syndrome after COVID-19.\",\"authors\":\"Svetlana D Miletic Drakulic, Snezana R Lazarevic, Ivana P Miloradovic, Vladimir S Jankovic\",\"doi\":\"10.17712/nsj.2023.4.20230012\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Coronavirus disease 19 (COVID-19) is known to manifest itself predominantly with respiratory symptoms. However, previous experiences with this disease and many scientific studies have drawn attention to its neurological manifestations. The link between COVID-19 and many neurological diseases, including Guillain Barré syndrome (GBS), has been pointed out. Although GBS is considered a monophasic disease, its relapses occur in 2-6% of cases. We present the case of a female patient with recurrent GBS caused by COVID-19. Given that 2-6% of patients experience a relapse of GBS, and that the COVID-19 pandemic is recognized as a possible trigger of the relapse, we emphasize the importance of intensive neurological monitoring for patients diagnosed with COVID-19 who have a history of GBS.\",\"PeriodicalId\":19284,\"journal\":{\"name\":\"Neurosciences\",\"volume\":\"28 4\",\"pages\":\"273-276\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2023-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10827027/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neurosciences\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.17712/nsj.2023.4.20230012\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurosciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.17712/nsj.2023.4.20230012","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

摘要

已知冠状病毒疾病19（新冠肺炎）主要表现为呼吸道症状。然而，以前对这种疾病的经验和许多科学研究都引起了人们对其神经表现的关注。新冠肺炎与包括格林-巴利综合征（GBS）在内的许多神经系统疾病之间的联系已被指出。尽管GBS被认为是一种单相疾病，但其复发发生率为2-6%。我们报告了一例女性患者因新冠肺炎引起的复发性GBS。鉴于2-6%的患者出现GBS复发，并且新冠肺炎大流行被认为是复发的可能诱因，我们强调对有GBS病史的新冠肺炎确诊患者进行强化神经监测的重要性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Reccurent guillain barré syndrome after COVID-19.

Coronavirus disease 19 (COVID-19) is known to manifest itself predominantly with respiratory symptoms. However, previous experiences with this disease and many scientific studies have drawn attention to its neurological manifestations. The link between COVID-19 and many neurological diseases, including Guillain Barré syndrome (GBS), has been pointed out. Although GBS is considered a monophasic disease, its relapses occur in 2-6% of cases. We present the case of a female patient with recurrent GBS caused by COVID-19. Given that 2-6% of patients experience a relapse of GBS, and that the COVID-19 pandemic is recognized as a possible trigger of the relapse, we emphasize the importance of intensive neurological monitoring for patients diagnosed with COVID-19 who have a history of GBS.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Neurosciences 医学-临床神经学

CiteScore

1.40

自引率

0.00%

发文量

审稿时长

4.5 months

期刊介绍： Neurosciences is an open access, peer-reviewed, quarterly publication. Authors are invited to submit for publication articles reporting original work related to the nervous system, e.g., neurology, neurophysiology, neuroradiology, neurosurgery, neurorehabilitation, neurooncology, neuropsychiatry, and neurogenetics, etc. Basic research withclear clinical implications will also be considered. Review articles of current interest and high standard are welcomed for consideration. Prospective workshould not be backdated. There are also sections for Case Reports, Brief Communication, Correspondence, and medical news items. To promote continuous education, training, and learning, we include Clinical Images and MCQ’s. Highlights of international and regional meetings of interest, and specialized supplements will also be considered. All submissions must conform to the Uniform Requirements.